EQT moves SHL Medical stake into long-term strategy fund
EQT has transferred its minority stake in Swiss drug delivery manufacturer SHL Medical to EQT Future, the GP's new impact-driven, longer-hold investment strategy.
More on DACH
IPEM 2023: GPs battle fundraising blues on the Côte d'Azur
Sponsors remain broadly optimistic despite fundraise bottlenecks and a growing number of LPs faced with tough choices on manager selection
Main Capital exits Onventis in SBO to Keensight
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
Latest News
21 Invest France eyes EUR 300m Fund VI target by year-end
Fund VI has raised half of its target so far, with the GP seeking to further prove its investment track record throughout 2023
IPEM 2023: GPs battle fundraising blues on the Côte d'Azur
Sponsors remain broadly optimistic despite fundraise bottlenecks and a growing number of LPs faced with tough choices on manager selection
Equistone to exit Acuity in sale to Permira
Sale of financial services research group follows process with early discussions between vendor and bidders
Clessidra on track for 2023 final close for debut private debt fund
GP has raised EUR 150m for the vehicle against a EUR 250m target, with one third already deployed